Chemours says top execs manipulated free cash flow, foresees no impact on results
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Chemours said on Wednesday that an internal review revealed its senior executives manipulated some vendor payments and collections of receivables in the fourth quarter of 2023 in part to meet free cash flow targets, tied to their incentives.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1803777103-b9626d35c9fd4424ae7ecc3b6d58a558.jpg "Accountant Career Path and Qualifications")
:max_bytes(150000):strip_icc():format(jpeg)/AFFLUENT.MILLENNIAL.HERO.GettyImages-868506558_2600-84706e45802340b1865d4b49c285a662.jpg "The Affluent Millennial Investing Survey")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2151279555-f38549a64433496982ff93944b309afb.jpg "5 Transamerica Mutual Funds to Consider")
